Volume 58, Issue 5, Pages (November 2000)

Slides:



Advertisements
Similar presentations
Volume 67, Issue 4, Pages (April 2005)
Advertisements

Volume 74, Issue 11, Pages (December 2008)
Volume 67, Issue 5, Pages (May 2005)
Robert S Poston, Margaret E Billingham, Jeffrey Pollard, E
Volume 58, Issue 4, Pages (October 2000)
Volume 78, Issue 11, Pages (December 2010)
Volume 79, Issue 1, Pages (January 2011)
Volume 88, Issue 3, Pages (September 2015)
Volume 117, Issue 2, Pages (August 1999)
Ravinder S. Chana, David C. Wheeler  Kidney International 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Robert S Poston, Margaret E Billingham, Jeffrey Pollard, E
Volume 56, Issue 5, Pages (November 1999)
Volume 61, Issue 2, (February 2002)
Volume 74, Issue 11, Pages (December 2008)
Volume 75, Issue 3, Pages (February 2009)
Volume 53, Issue 4, Pages (April 1998)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Volume 54, Issue 4, Pages (October 1998)
Genistein protects the kidney from cisplatin-induced injury
Volume 75, Issue 2, Pages (January 2009)
Volume 63, Issue 4, Pages (April 2003)
Volume 64, Issue 1, Pages (July 2003)
Volume 79, Issue 1, Pages (January 2011)
Volume 63, Issue 1, Pages (January 2003)
Volume 70, Issue 2, Pages (July 2006)
Volume 84, Issue 4, Pages (October 2013)
Volume 60, Issue 1, Pages (July 2001)
Volume 54, Issue 6, Pages (January 1998)
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 58, Issue 3, Pages (September 2000)
Volume 61, Issue 3, Pages (March 2002)
Volume 64, Issue 5, Pages (November 2003)
Volume 58, Issue 3, Pages (September 2000)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Volume 60, Issue 6, Pages (December 2001)
Volume 87, Issue 2, Pages (February 2015)
Shinichi Kanno, MD, PhDa, Paul C. Lee, MDb, Stephen J
Volume 73, Issue 12, Pages (June 2008)
Proteasome inhibitor-based therapy for antibody-mediated rejection
Volume 56, Issue 3, Pages (September 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 59, Issue 3, Pages (March 2001)
Volume 60, Issue 6, Pages (December 2001)
Volume 67, Issue 4, Pages (April 2005)
Volume 74, Issue 5, Pages (September 2008)
An unusual cause of acute renal failure
Volume 67, Issue 5, Pages (May 2005)
Volume 75, Issue 5, Pages (March 2009)
Volume 79, Issue 2, Pages (January 2011)
Volume 74, Issue 1, Pages (July 2008)
Volume 64, Issue 3, Pages (September 2003)
Volume 74, Issue 11, Pages (December 2008)
Volume 61, Issue 1, Pages (January 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 68, Issue 5, Pages (November 2005)
Volume 56, Issue 5, Pages (November 1999)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
The treatment of acute interstitial nephritis: More data at last
Volume 71, Issue 12, Pages (June 2007)
Endothelial cell activation
Volume 62, Issue 1, Pages (July 2002)
Volume 63, Issue 1, Pages (January 2003)
The more or less ‘pristine’ renal allograft biopsy
The Case | Peculiar fibrous nodules in a renal transplant biopsy
Volume 60, Issue 3, Pages (September 2001)
Volume 65, Issue 3, Pages (March 2004)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 54, Issue 2, Pages (August 1998)
Presentation transcript:

Volume 58, Issue 5, Pages 2166-2177 (November 2000) Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background  Duska Dragun, Uwe Hoff, Joon Keun Park, Yan Qun, Wolfgang Schneider, Friedrich C. Luft, Hermann Haller  Kidney International  Volume 58, Issue 5, Pages 2166-2177 (November 2000) DOI: 10.1111/j.1523-1755.2000.00390.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Renal function parameters of rats with isografts and allografts at the given time points. (A) Serum creatinine concentration. (B) Serum urea concentration. Symbols are: (•) isografts; (▪) allografts. Both parameters are expressed in mg/dL as means ± SEM. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Immunostaining for P-selectin two hours after transplantation. Vascular expression: (A) isograft; (B) allograft; (C) native kidney. Intraglomerular expression: (D) isograft; (E) allograft; (F) native kidney. Original magnification ×400. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Immunostaining for L-selectin six hours after transplantation in an (A) isograft, (B) allograft, and (C) native kidney. Original magnification ×400. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Immunostaining for intercellular adhesion molecule-1 (ICAM-1) and platelet-endothelial cellular adhesion molecule-1 (PECAM-1) 24 hours after transplantation. ICAM-1: (A) isograft; (B) allograft; (C) native kidney. PECAM-1: (D) isograft; (E) allograft; (F) native kidney. Original magnification ×200. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Immunostaining for vascular cellular adhesion molecule-1 (VCAM-1) 24 hours after transplantation. Arterioles: (A) isograft; (B) allograft; (C) native kidney. Vascular poles: (E) isograft; (D) allograft; (F) native kidney. Original magnification ×400. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Effect of ischemia-reperfusion injury on kinetics of different leukocyte populations. Data are expressed as a number of positively labeled cells counted in 15 randomly chosen fields of view in sections of allografts (▪) and isografts (•) during the time course studied. (A) Number of infiltrating neutrophils. (B) Number of LFA-1–positive cells. (C) Number of ED-1–positive monocytes/macrophages. (D) Number of VLA-4–positive cells. All results are expressed as means ± SEM. *P = 0.001. nk, native kidney. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 Immunostaining for neutrophils and LFA-1 in postischemic isografts and allografts. Perivascular neutrophil infiltrates: (A) isograft; (B) allograft. Intraglomerular neutrophil infiltrates: (C) isograft; (D) allograft. Perivascular LFA-1–positive infiltrates: (E) isograft; (F) allograft. Intraglomerular LFA-1–positive infiltrates: (G) isograft; (H) Allograft. Original magnification ×400. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 8 Immunostaining for ED-1–positive monocytes/macrophages and VLA-4 in isografts and allografts 24 hours after transplantation. Perivascular ED1–positive infiltrates: (A) isograft; (B) allograft. Intraglomerular ED1–positive infiltrates: (C) isograft; (D) allograft. Perivascular VLA-4–positive infiltrates: (E) isograft; (F) allograft. Intraglomerular VLA-4–positive infiltrates: (G) isograft; (H) allograft. Original magnification ×400. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 9 Renal histology (hematoxylin and eosin) showing features of acute tubular necrosis (ATN) in isografts (left panels) and allografts (right panels) 24 hours after transplantation (A and B) and acute rejection in nonimunosuppressed allografts after 10 days (C). Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 10 Influence of low and standard cyclosporine A (CsA) doses on infiltrates with ED-1–positive monocytes/macrophages and ED-2–positive activated macrophages-dendritic phenotype 7 and 10 days after transplantation. Both ED-1 (▪) and ED-2 (?) cells were detected at day 7 with both CsA treatments. At day 10, CsA dose-dependently decreased ED-1–positive cells. All results are expressed as means ± SEM. NK is native kidney; *P = 0.001. Kidney International 2000 58, 2166-2177DOI: (10.1111/j.1523-1755.2000.00390.x) Copyright © 2000 International Society of Nephrology Terms and Conditions